AI Research
In-depth reports and analysis on AI trends shaping the industry.
AI-Driven Personalized Nutrition & Lifestyle Interventions: Adoption, Integration, & Health ROI
May 2026
The convergence of artificial intelligence with multi-omics and digital biomarker data is revolutionizing personalized nutrition and lifestyle interventions, moving beyond generalized health advice to truly individualized care. The global personalized nutrition market, valued at approximately $10.6
AI's Transformative Impact on Experimental Design & Multi-Omics Data Synthesis in Biological Research: Adoption, ROI, & Future Trends
April 2026
AI is fundamentally reshaping biological research, particularly in experimental design and multi-omics data synthesis, driving unprecedented efficiencies and accelerating discovery across the life sciences. This report details the escalating adoption, measurable return on investment, and evolving te
AI-Driven Biomanufacturing Optimization: Market Adoption, ROI Benchmarks, and Technology Landscape
March 2026
The biopharmaceutical manufacturing sector is undergoing a profound transformation driven by the accelerating integration of Artificial Intelligence (AI) and Machine Learning (ML). This report synthesizes current market adoption, quantifies return on investment (ROI) benchmarks, and assesses the evo
AI-Driven Optimization of Lab Operations & Data Management: ROI, Adoption Trends, and Implementation Strategies
March 2026
Artificial Intelligence (AI) is rapidly transforming laboratory operations and data management across critical sectors including Pharmaceutical & Drug Development, Biotechnology Startups, Academic Research, and Clinical Research Organizations. This report analyzes the burgeoning market, quantifiable
Microbiome Analysis & Therapeutics: Market Analysis & Vendor Guide
February 2026
Enterprises face a rapidly evolving microbiome analysis & therapeutics vendor landscape. This study provides an independent assessment of 5 platforms — including Caporaso Lab / University of Northern Arizona (community-maintained), CosmosID, Inc., Seres Therapeutics, Inc., Vedanta Biosciences, Inc.,...
Computational Imaging & Pathology AI: Vendor Benchmark
February 2026
The computational imaging & pathology segment has reached a maturity inflection point. With 45% of pathology departments have deployed AI-assisted diagnostic imaging tools, enterprises are no longer asking whether to invest in AI-powered solutions — they're asking which vendor to choose. This benchm...
Single-Cell & Spatial Biology: Technology Landscape Report
February 2026
This report analyzes 1 single-cell & spatial biology vendors serving the global industry. The market, projected to reach $3.6 billion by 2028, is being reshaped by spatial multi-omics at subcellular resolution revealing tissue architecture insights invisible to bulk methods. Our analysis evaluates p...
Organ-on-Chip & Organoids: Platform Comparison & ROI Analysis
February 2026
40% of preclinical drug programs now incorporate organ-on-chip or organoid models — a figure that has doubled in three years and shows no sign of plateauing. Against this backdrop, this report evaluates 5 organ-on-chip & organoids platforms to help VP Preclinical Development and Head of In Vitro Mod...
Longevity & Anti-Aging Technology: Vendor Assessment Report
February 2026
As the longevity & anti-aging technology market accelerates toward $4.3 billion by 2028, enterprise buyers need objective data to separate proven platforms from overpromising newcomers. This report delivers that data across 5 vendors, with detailed assessments of Altos Labs, Inc., Retro Biosciences,...
Bioinformatics Platforms: Vendor Landscape & Performance Data
February 2026
Enterprises face a rapidly evolving bioinformatics platforms vendor landscape. This study provides an independent assessment of 1 platforms — including Seqera Labs (Open Source) — grounded in deployment data, capability analysis, and pricing benchmarks. The core finding: no-code bioinformatics workf...
Wearable Biotech & Digital Biomarkers: Vendor Comparison Study
February 2026
The wearable biotech & digital biomarkers segment has reached a maturity inflection point. With 50% of clinical trials now incorporate digital biomarker endpoints from wearable devices, enterprises are no longer asking whether to invest in AI-powered solutions — they're asking which vendor to choose...
Generative Biology Platforms: Market Analysis & Technology Assessment
February 2026
This report analyzes 4 generative biology vendors serving the global industry. The market, projected to reach $1.9 billion by 2028, is being reshaped by diffusion models and language models trained on biological sequences generating novel functional molecules. Our analysis evaluates platforms across...
CRISPR & Gene Editing Design Tools: Vendor Benchmark
February 2026
70% of gene therapy programs now use computational guide RNA design tools — a figure that has doubled in three years and shows no sign of plateauing. Against this backdrop, this report evaluates 10 crispr & gene editing design platforms to help Head of Gene Therapy and VP Genetic Medicine profession...
Bioelectronic Medicine: Vendor Landscape & Clinical Evidence Review
February 2026
As the bioelectronic medicine & neurostimulation market accelerates toward $1.8 billion by 2028, enterprise buyers need objective data to separate proven platforms from overpromising newcomers. This report delivers that data across 5 vendors, with detailed assessments of electroCore, Inc., SetPoint ...
Cloud Labs & Remote Research: Platform Comparison Study
February 2026
Enterprises face a rapidly evolving cloud labs & remote research vendor landscape. This study provides an independent assessment of 1 platforms — including Emerald Cloud Lab, Inc. — grounded in deployment data, capability analysis, and pricing benchmarks. The core finding: API-driven experiment exec...
Digital Twins & In Silico Trials: Vendor Benchmark & ROI Analysis
February 2026
The digital twins & in silico trials segment has reached a maturity inflection point. With 35% of clinical trial sponsors now use in silico modeling to optimize trial design, enterprises are no longer asking whether to invest in AI-powered solutions — they're asking which vendor to choose. This benc...
Brain-Computer Interfaces: Technology Assessment & Vendor Comparison
February 2026
This report analyzes 5 brain-computer interfaces & neurotech vendors serving the global industry. The market, projected to reach $3.7 billion by 2028, is being reshaped by minimally invasive and non-invasive BCI approaches expanding beyond implantable electrode arrays. Our analysis evaluates platfor...
Surgical & Biomedical Robotics: Market Analysis & Vendor Guide
February 2026
80% of major academic medical centers now have at least one surgical robotics platform — a figure that has doubled in three years and shows no sign of plateauing. Against this backdrop, this report evaluates 5 surgical & biomedical robotics platforms to help Chief of Surgery and VP Medical Technolog...
Precision Medicine & Diagnostics AI: Technology Assessment
February 2026
As the precision medicine & diagnostics market accelerates toward $3.8 billion by 2028, enterprise buyers need objective data to separate proven platforms from overpromising newcomers. This report delivers that data across 4 vendors, with detailed assessments of Tempus AI, Inc., Foundation Medicine,...
Lab Automation & Robotics: Platform Comparison & ROI Analysis
February 2026
Enterprises face a rapidly evolving lab automation & robotics vendor landscape. This study provides an independent assessment of 3 platforms — including Opentrons Labworks, Inc., Hamilton Company, Automata Technologies Ltd. — grounded in deployment data, capability analysis, and pricing benchmarks. ...
Foundation Models for Biology: Market Analysis & Vendor Guide
February 2026
The foundation models for biology segment has reached a maturity inflection point. With 45% of biotech R&D teams have integrated biological foundation models into their discovery pipelines, enterprises are no longer asking whether to invest in AI-powered solutions — they're asking which vendor to ch...
Computational Chemistry Platforms: Vendor Benchmark & Assessment
February 2026
This report analyzes 2 computational chemistry vendors serving the global industry. The market, projected to reach $2.1 billion by 2028, is being reshaped by physics-informed neural networks replacing classical force field simulations for binding affinity prediction. Our analysis evaluates platforms...
Genomics & Sequencing AI: Platform Comparison Study
February 2026
82% of clinical genomics labs use AI-assisted variant interpretation — a figure that has doubled in three years and shows no sign of plateauing. Against this backdrop, this report evaluates 4 genomics & sequencing ai platforms to help Director of Genomics and Chief Medical Officer professionals make...
Synthetic Biology Platforms: Technology Landscape Report
February 2026
As the synthetic biology platforms market accelerates toward $2.8 billion by 2028, enterprise buyers need objective data to separate proven platforms from overpromising newcomers. This report delivers that data across 11 vendors, with detailed assessments of Ginkgo Bioworks Holdings, Inc., Moderna, ...
Electronic Lab Notebooks: Vendor Analysis & Comparison
February 2026
Enterprises face a rapidly evolving electronic lab notebooks vendor landscape. This study provides an independent assessment of 3 platforms — including Benchling, Inc., Sapio Sciences, LLC, Dotmatics Limited — grounded in deployment data, capability analysis, and pricing benchmarks. The core finding...
Protein Structure & Design AI: Vendor Evaluation & Performance Data
February 2026
The protein structure & design segment has reached a maturity inflection point. With 65% of structural biology labs now incorporate AI-predicted structures into their workflows, enterprises are no longer asking whether to invest in AI-powered solutions — they're asking which vendor to choose. This b...
AI Drug Discovery Platforms: Vendor Landscape & Benchmark
January 2026
This report analyzes 6 ai drug discovery vendors serving the global industry. The market, projected to reach $4.5 billion by 2028, is being reshaped by generative chemistry and multimodal foundation models replacing traditional HTS-only approaches. Our analysis evaluates platforms across AI sophisti...